Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARROWHEAD PHARMACEUTICALS IN
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 1.3M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $83.7M as of 2025-Q4. The position was decreased (-28.4% shares). ARWR represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$83.7M
Current Shares
1.3M
Total Value Change
+$24.2M
Total Shares Change
-1M
Other major holders of ARWR: BANQUE PICTET & CIE SA, BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 1.3M |
-28.4% |
| $83.7M |
| 0.0% |
| $67.25 |
0 |
| 2025-Q3 | Decreased | 1.8M | -34.5% | $60.7M | 0.0% | $33.78 | 0 |
| 2025-Q2 | Decreased | 2.7M | -43.9% | $42.4M | 0.0% | $16.08 | 0 |
| 2025-Q1 | Increased | 4.8M | +138.1% | $61M | 0.0% | $13.82 | 48 |
| 2024-Q4 | Decreased | 2M | -6.7% | $37.8M | 0.0% | $18.61 | 0 |
| 2024-Q3 | Decreased | 2.2M | -5.9% | $41.7M | 0.0% | $19.67 | 0 |
| 2024-Q2 | Increased | 2.3M | +145.2% | $59.5M | 0.0% | $25.99 | 48 |